William Shomali

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 14

Top Topics

Sickle Cell Disease

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

American journal of hematology

British journal of haematology

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

William Shomali, Jason Gotlib
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (5) (2024)
William Shomali, Jason Gotlib
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (5) (2024)
William Shomali, Jason Gotlib
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. American journal of hematology (2024)
William Shomali, Jason Gotlib
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management. American journal of hematology 99 (5) (2024)
Vanessa E Kennedy, Cecelia Perkins, Andreas Reiter, Mohamad Jawhar, Johannes Lübke, Hanneke C Kluin-Nelemans, William Shomali, Cheryl Langford, Justin Abuel, Olivier Hermine, Marek Niedoszytko, Aleksandra Gorska, Andrzej Mital, Patrizia Bonadonna, Roberta Zanotti, Riccardo Bazzoni, Mattias Mattsson, Hans G Hagglund, Massimo Triggiani, Akif Selim Yavuz, Jens Peter Panse, Deborah Christen, Marc Heizmann, Khalid Shoumariyeh, Sabine Müller, Chiara Elena, Luca Malcovati, Nicolas Fiorelli, Friederike Wortmann, Vladan Vucinic, Knut Brockow, Christos Fokoloros, Sotirios G Papageorgiou, Christine Breynaert, Dominique M A Bullens, Michael Doubek, Anja Ilerhaus, Irena Angelova-Fischer, Oleksii Solomianyi, Judit Varkonyi, Vito Sabato, Axel Rüfer, Tanja Schug, Maud A W Hermans, Anna Belloni Fortina, Francesca Caroppo, Horia Bumbea, Theo Gulen, Karin Hartmann, Joanne N G Oude Elberink, Juliana Schwaab, Michel Arock, Peter Valent, Wolfgang Sperr, Jason Gotlib
Mast Cell Leukemia: Clinical and Molecular Features and Survival Outcomes of Patients in the ECNM Registry. Blood advances (2022)
Haiyu Zhang, May Chien, Yu Hou, William Shomali, Rondeep Brar, Chandler Ho, Panpan Han, Danfei Xu, Bing M Zhang, Xiangqian Guo, Lorna Tolentino, Nancy C Wu, Albert G Tsai, Jing Jin, Wesley Holbrook Witteles, Zhenping Chen, Parveen Abidi, Diwash Jangam, Madison S Krieger, Morgan Craig, James B Bussel, Jason R Gotlib, James L Zehnder
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3, and MPL mutations. Blood advances (2022)
William Shomali, Jason Gotlib
World Health Organization-defined eosinophilic disorders: 2021 update on diagnosis, risk stratification, and management. American journal of hematology (2021)
Nicole Naumann, Johannes Lübke, William Shomali, Lukas Reiter, Hans-Peter Horny, Mohamad Jawhar, Vito Dangelo, Alice Fabarius, Georgia Metzgeroth, Sebastian Kreil, Karl Sotlar, Claire Oni, Claire Harrison, Wolf-Karsten Hofmann, Nicholas C P Cross, Peter Valent, Deepti H Radia, Jason Gotlib, Andreas Reiter, Juliana Schwaab
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations. British journal of haematology 194 (2) (2021)
William Shomali, Alisa Damnernsawad, Talent Theparee, David Sampson, Quinlan Morrow, Fei Yang, Sebastian Fernandez-Pol, Richard D Press, James L Zehnder, Jeffrey W Tyner, Jason Gotlib
A novel activating JAK1 mutation in chronic eosinophilic leukemia. Blood advances 5 (18) (2021)
William Shomali, Jason Gotlib
World Health Organization-defined eosinophilic disorders: 2019 update on diagnosis, risk stratification, and management. American journal of hematology 94 (10) (2020)
Armon Azizi, Asiri Ediriwickrema, Ritika Dutta, Shyam A Patel, William Shomali, Bruno Medeiros, David Iberri, Jason Gotlib, Gabriel Mannis, Peter Greenberg, Ravindra Majeti, Tian Yi Zhang
Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience. Leukemia & lymphoma 61 (11) (2020)
William Shomali, Jason Gotlib
Myelophthisic marrow involved by breast cancer and acute myeloid leukemia. Blood 131 (9) (2019)
William Shomali, Rondeep Brar, Subramanyeswara R Arekapudi, Jason R Gotlib
A Kindred with a β-Globin Base Substitution [β89(F5)Ser→Arg (AGT>AGG); HBB: c.270T>G] Resulting in Hemoglobin Vanderbilt. Hemoglobin 43 (4-5) (2019)
William Shomali, Rondeep Brar
Late presentation of dyskeratosis congenita. British journal of haematology 187 (3) (2019)